MetaFlow Health

Physicians

MetaFlow is

designed for patients with chronic Cardio-Kidney-Metabolic or Musculoskeletal patterns who may benefit from physician-supervised, home-based, non-pharmacological execution.

Referral Criteria

Appropriate referrals may include patients with chronic health patterns related to abnormal blood glucose, abnormal blood pressure, lipid abnormalities, fatty liver, atherosclerotic risk, kidney-related risk markers, chronic musculoskeletal pain, functional limitation, reduced mobility, or long-term decline in daily physical function.

MetaFlow may be especially relevant for patients whose symptoms, markers, and functional limitations appear to involve multiple connected systems rather than a single isolated diagnosis. The model is designed to evaluate the patient’s broader imbalance state and translate that assessment into a structured home-execution protocol with ongoing reassessment.

Patients may be considered for referral when they are clinically stable, able to participate in home-based execution, able to report symptoms and tolerance, and willing to complete structured follow-up and reassessment.

MetaFlow is not intended for patients requiring emergency care, acute stabilization, immediate medication adjustment, inpatient-level management, or high-intensity specialist intervention. Patients with red-flag symptoms, unstable clinical status, severe organ failure, active infection, significant immunosuppression, post-transplant status, or other high-risk features may not be appropriate for MetaFlow and may be redirected to higher-level medical care.

MetaFlow does not replace the referring physician, primary care physician, specialist, emergency care, or medication management. Medication decisions remain under the responsibility of the patient’s licensed treating clinicians. MetaFlow provides a supervised non-pharmacological execution layer, structured tracking, risk review, reassessment, and protocol refinement.

Clinical Governance

MetaFlow’s outcomes framework is designed to report real-world results across Cardio-Kidney-Metabolic and Musculoskeletal populations as sufficient longitudinal data becomes available.

  1. 1

    Step 1

    Structured Intake

    Each patient begins with a structured clinical review that may include health history, current symptoms, recent laboratory results, imaging records where available, medications, risk factors, care context, and functional status. This review is used to assess eligibility, identify the patient’s dominant imbalance patterns, and determine whether home-based non-pharmacological execution is appropriate.

  2. 2

    Step 2

    Protocol Generation & Supervision

    If the patient is appropriate for MetaFlow, a personalized execution signal protocol is generated and reviewed under physician supervision. The protocol is tailored to the patient’s imbalance state, risk profile, tolerance, and available clinical data. It is not intended to replace medication management or disease-specific care directed by the patient’s existing clinicians.

  3. 3

    Step 3

    Continuous Tracking & Escalation

    During execution, patients report symptoms, adherence, tolerance, functional changes, and potential warning signs through structured tracking. Concerning changes, poor tolerance, abnormal symptom patterns, red-flag symptoms, unstable clinical status, or potential adverse events are escalated for physician review. When appropriate, the protocol may be adjusted, paused, or discontinued, and the patient may be directed back to their primary care physician, specialist, urgent care, or emergency services.

  4. 4

    Step 4

    Protocol Versioning & Documentation

    MetaFlow maintains protocol versioning and documentation over time. Intake findings, protocol versions, reassessment results, symptom changes, adherence patterns, escalation events, and clinical rationale are recorded to create an auditable care history.

  5. 5

    Step 5

    Monthly Reassessment & Trajectory Tracking

    Monthly reassessment may include laboratory testing, imaging follow-up where appropriate, symptom review, functional tracking, and quality-of-life assessment. The purpose is to determine not only whether individual markers are changing, but whether the patient’s broader clinical trajectory is moving in a coordinated and clinically meaningful direction.

  6. 6

    Step 6

    Governance Grounding

    MetaFlow’s clinical governance model is grounded in physician oversight, defined safety boundaries, red-flag escalation, objective reassessment, and documented protocol refinement.

Red Flags & Escalation

MetaFlow is designed for clinically appropriate home-based execution, not for emergency care, acute stabilization, or unmanaged high-risk medical conditions.

Red-flag symptoms, unstable clinical status, poor tolerance, abnormal symptom patterns, or potential adverse events are escalated for physician review. When appropriate, the MetaFlow protocol may be adjusted, paused, or discontinued, and the patient may be directed back to their primary care physician, specialist, urgent care, or emergency services.

Examples of red-flag concerns may include acute chest pain, severe shortness of breath, sudden neurological symptoms, severe or rapidly worsening pain, signs of acute infection, syncope, uncontrolled bleeding, significant medication-related concerns, severe functional decline, or any clinical change suggesting that the patient requires immediate medical evaluation.

MetaFlow also reviews patients for high-risk features before and during participation. Patients with unstable medical conditions, severe organ failure, active infection, significant immunosuppression, post-transplant status, or other high-risk clinical factors may be excluded or redirected to higher-level care.

Escalation decisions are documented as part of the patient’s clinical governance record, including the concern identified, physician review where applicable, protocol action, and recommended care pathway.

Physician Resources

MetaFlow is developing physician-facing resources to support appropriate referral, clinical collaboration, and transparent outcome interpretation.

These resources may include referral guidance, eligibility criteria, safety and red-flag criteria, care pathway summaries, reassessment schedules, measurement frameworks, protocol governance standards, and outcome reporting methodology. For referred patients, MetaFlow may provide structured summaries that help physicians understand the patient’s intake findings, imbalance-state assessment, protocol status, adherence patterns, reassessment results, safety events, and protocol adjustments over time.

MetaFlow’s goal is to make the home-execution layer visible, structured, and clinically accountable, so that physicians can understand what the patient is doing at home, how the patient is being monitored, and when escalation or care coordination may be needed.

Physician resources will continue to expand as MetaFlow’s ACCESS implementation progresses and additional real-world care data becomes available.

Clinical Inquiry

Physicians who are interested in referring patients, learning more about MetaFlow’s clinical model, or discussing potential collaboration may submit a clinical inquiry.

Clinical inquiries may include questions about referral fit, eligibility criteria, patient safety, protocol governance, CKM or MSK focus areas, reassessment methodology, outcome reporting, or physician collaboration. MetaFlow reviews clinical inquiries to determine the appropriate next step, which may include providing additional information, scheduling a clinical discussion, clarifying referral criteria, or directing the physician to the appropriate access pathway.

MetaFlow is especially interested in working with physicians who are caring for patients with chronic Cardio-Kidney-Metabolic or Musculoskeletal patterns where symptoms, markers, and functional limitations may reflect a broader systemic imbalance rather than a single isolated condition.

The Ultimate Goal

The goal is to help patients and clinical teams see not only whether individual markers are changing, but whether the body as a whole is moving back toward balance.